DMEMEDS shared post via Reuters: Europe approves Takeda drug for ulcerative colitis, Crohn's disease

TOKYO (Reuters) - The European Commission has approved the sale of Takeda Pharmaceutical Co Ltd's Entyvio drug to treat patients with ulcerative colitis and Crohn's disease, Japan's biggest drugmaker said on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/f304SLDdDQ8/story01.htm

Read More